BMC Gastroenterology (Mar 2021)

Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study

  • David Tornai,
  • Peter Antal-Szalmas,
  • Tamas Tornai,
  • Maria Papp,
  • Istvan Tornai,
  • Nora Sipeki,
  • Tamas Janka,
  • Boglarka Balogh,
  • Zsuzsanna Vitalis

DOI
https://doi.org/10.1186/s12876-021-01669-w
Journal volume & issue
Vol. 21, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Background Both iron overload and iron deficient anemia can associate with cirrhosis. At the same time, inflammation might be continuously present in cirrhotic patients due to bacterial translocation and patients’ susceptibility to infections. Ferritin is a sensitive and widely available marker of iron homeostasis, in addition it acts as an acute phase protein. Therefore, we evaluated the prognostic potential of serum ferritin in the long-term follow-up of cirrhotic outpatients. Methods A cohort of 244 cirrhotic outpatients was recruited and followed for 2 years. We measured their serum ferritin levels in our routine laboratory unit at enrolment and investigated its association with clinical outcomes. Results Ferritin serum level was higher in males and older patients than in females (median: 152.6 vs. 75 μg/L, p 310 μg/L) circulating ferritin levels were associated with increased risks of bacterial infections in decompensated patients (sHR: 2.335, CI 1.193–4.568, p = 0.013) and mortality in the whole population (HR: 2.143, CI 1.174–3.910, p = 0.013). Conclusion We demonstrated usefulness of serum ferritin as a prognostic biomarker in cirrhosis, pointing out that both low and high concentrations need attention in these patients.

Keywords